Barchart.com
[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.

Icosavax Inc (ICVX)

Icosavax Inc (ICVX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Help
Go To:
Oracle's Falling, but You Won't Want to Miss This Soaring Biotech Stock Motley Fool - Tue Dec 12, 2023

Tuesday brought favorable inflation data, and bullish investors are looking for stock winners.

AZN : 182.52 (-1.30%)
ORCL : 194.59 (+0.29%)
ICVX : 15.31 (-0.91%)
Why Shares of Icosavax Jumped on Tuesday Motley Fool - Tue May 23, 2023

The company announced positive trial news for its pan-virus vaccine.

ICVX : 15.31 (-0.91%)
Icosavax Announces Results from IVX-411 Drug Product Investigation and Outlines Additional Corporate Milestones Globe Newswire - Thu Jul 28, 2022

- Antigen component of IVX-411 found to be unstable; issue specific to molecule, with no evidence of read-through to other Icosavax programs - - Now...

ICVX : 15.31 (-0.91%)
Icosavax to Participate in the William Blair Biotech Focus Conference Globe Newswire - Wed Jul 6, 2022

SEATTLE, July 06, 2022 (GLOBE NEWSWIRE) -- Icosavax, Inc. (Nasdaq: ICVX), a biopharmaceutical company leveraging its innovative virus-like particle (VLP)...

ICVX : 15.31 (-0.91%)
Icosavax Announces Positive Topline Interim Phase 1/1b Results for VLP Vaccine Candidate IVX-121 Against RSV Globe Newswire - Tue Jun 28, 2022

- IVX-121 demonstrated robust immunologic response to RSV, with comparable Geometric Mean Titer (GMT) levels achieved at Day 28 in both young and older...

ICVX : 15.31 (-0.91%)
Icosavax to Participate in the Jefferies Healthcare Conference Globe Newswire - Wed Jun 1, 2022

SEATTLE, June 01, 2022 (GLOBE NEWSWIRE) -- Icosavax, Inc. (Nasdaq: ICVX), a biopharmaceutical company leveraging its innovative virus-like particle...

ICVX : 15.31 (-0.91%)

Barchart Exclusives

Western Digital Just Increased Its Dividend by 20% but It’s Still Not a Yield Play Barchart - Thu May 7, 6:30PM CDT
The company will now pay a dividend of $0.15 per share every quarter. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.